• Home >
  • Publications >
  • The combination of radiotherapy and ALK inhibitors is effective in the treatment of intraosseous rhabdomyosarcoma with FUS‐TFCP2 fusion transcript

The combination of radiotherapy and ALK inhibitors is effective in the treatment of intraosseous rhabdomyosarcoma with FUS‐TFCP2 fusion transcript

1 May 2020Pediatric Blood & Cancer

DOI : 10.1002/pbc.28185

Authors

Anne‐Cécile Brunac, Anne Laprie, Marie‐Pierre Castex, Camille Laurent, François Le Loarer, Marie Karanian, Sophie Le Guellec, Delphine Guillemot, Gaelle Pierron, Anne Gomez‐Brouchet